stockrow
Monday 9 November 2026
Export CMPX’s income statement to Excel — free account
Compass Therapeutics, Inc.
CMPXCompass Therapeutics, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $850,000.00.
- EPS
- +7.14%
- Free cash flow
- −26.1%
Quarter to June 2026, against a year earlier
0.76
0.08
+11.76%
Follow CMPX
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
11.15 | 18.94 | 14.96 | 17.72 | |
Current Ratio |
11.22 | 19.04 | 15.02 | 17.82 | |
Net Debt/EBITDA |
6.71 | 9.67 | 11.10 | 13.90 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.59 | 0.94 | 0.84 | 0.76 | |
Capex/Depreciation |
(0.99) | (0.51) | 0.00 | 1.75 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.08) | (0.09) | (0.08) | (0.06) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.08) | (0.09) | (0.08) | (0.06) | |
Cash per Share |
0.96 | 1.04 | 1.32 | 1.30 | |
Shareholders Equity per Share |
0.89 | 1.00 | 1.25 | 1.24 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.89 | 1.00 | 1.25 | 1.24 | |
Free Cash Flow |
(14.91) | (17.35) | (13.25) | (10.86) | |
Working Capital |
164.76 | 185.41 | 195.85 | 208.71 | |
Capital Expenditures |
(0.18) | (0.08) | 0.00 | (0.01) | |
Net Current Asset Value |
156.77 | 176.99 | 187.02 | 199.47 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Payables |
2.75 | 1.24 | 1.92 | 2.03 | |
Average Assets |
153.44 | 168.31 | 180.00 | 190.21 | |
Average Common Equity |
129.63 | 148.38 | 161.01 | 174.01 |
Columns are period end dates · fundamentals updated 2 Nov 2026